Sun Says FDA Clears Two U.S. Drug Facilities Of GMP Violations
This article was originally published in PharmAsia News
Executive Summary
Sun Pharmaceutical said its Caraco Pharmaceutical Laboratories unit in the U.S. has been returned to compliance with good manufacturing practices, having fixed problems that led to U.S. FDA action in 2009.
Sun Pharmaceutical said its Caraco Pharmaceutical Laboratories unit in the U.S. has been returned to compliance with good manufacturing practices, having fixed problems that led to U.S. FDA action in 2009. The agency seized drugs made at the Michigan production and packing facilities, leading to a consent decree with the India-based company. Two drugs were unblocked in August 2012. (Click here for more
)
"Sun Pharma Says Issues With U.S. Health Regulator At Caraco Facility Addressed" - NDTV (India) (10/28/2013)